A monoclonal antibody to gastrin was used to study the role of circula
ting gastrin in mediating insulin-stimulated acid output. On separate
days, seven adult dogs with chronic gastric fistulas were pretreated I
V with either 1) 7 mg of a gastrin monoclonal antibody (mAb 28.2); 2)
12.5 mu g/kg atropine; 3) mAb 28.2 and atropine together; or 4) vehicl
e (0.1% canine serum albumin in 0.15 M NaCl). Thirty minutes later, ac
id secretion was stimulated by insulin (0.5 U/kg, IV), followed in 2 h
by a 1-h infusion of histamine (40 mu g/kg/h, IV). Acid output (mmol/
15 min) in gastric effluent collected through the gastric fistula was
determined by titration with 0.2 N NaOH to pH 7.0. Plasma gastrin was
measured by radioimmunoassay. Plasma glucose was measured by a glucose
oxidase method on an auto analyzer. Insulin induced a profound hypogl
ycemia (55 +/- 8 mg/dl) that coincided with a marked increase in acid
output to 7.1 +/- 0.6 mmol/30 min by 45 min after injection. MAb 28.2
pretreatment and atropine pretreatment reduced insulin-stimulated acid
outputs to 2.7 +/- 0.7 mmol/30 min and to 0.6 +/- 0.2 mmol/ 30 min, r
espectively. Acid output after combined pretreatment (0.5 +/- 0.2 mmol
/30 min) was not significantly different than after atropine alone. Hi
stamine-stimulated acid output (15.8 +/- 2.5 mmol/30 min) was not sign
ificantly reduced by any pretreatment. Insulin injection increased cir
culating gastrin concentrations to 32 +/- 7 fmol/ml, which was not sig
nificantly affected by atropine (39 +/- 9 fmol/ml). This study demonst
rates that, in dogs, a significant part of insulin-stimulated acid sec
retion is mediated by circulating gastrin.